Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01700725 · ClinicalTrials.gov registry record · Phase 2

Gulf War Illness Nasal Irrigation Study

A Phase 2 study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
Phase 2
Development phase
40
Enrollment target

NCT01700725: Completed Phase 2 study, sponsored by University of Wisconsin, Madison.

NCT01700725 is a Phase 2 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 40 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01700725, a Phase 2 study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
Phase 2
Development phase
40 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether nasal irrigation with Xylitol or saline are effective in the treatment of chronic rhinosinusitis and fatigue symptoms associated with Gulf War Illness.

Primary Outcome

Sino-Nasal Outcome Test (SNOT-20) is a recommended tool for clinical trial research involving CRS. Sinus disease specific quality of life will be measured using the total score of this validated 20 item questionnaire. It is a reliable and valid outcome measure for patients with CRS (Cronbach's α 0.9, test-retest r = 0.9) that describes the health burden and is sensitive to clinical change. Patients who are more affected by CRS tend to have greater SNOT-20 scores (P \< 0.01). The SNOT-20 score is

Interventions

  • OTHER Nasal Irrigation - Saline
  • DRUG Nasal Irrigation - Xylitol

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2012-10
Est. Completion 2017-05
Phase Phase 2
University of Wisconsin, Madison

1,039 total trials

What the finished NCT01700725 record still lists

NCT01700725 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (70% lower).

The record links to 0 conditions, and to 2 interventions - of which Nasal Irrigation - Saline is the first listed.

NCT01700725 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01700725 about?

NCT01700725 is a clinical study titled "Gulf War Illness Nasal Irrigation Study". The purpose of this study is to determine whether nasal irrigation with Xylitol or saline are effective in the treatment of chronic rhinosinusitis and fatigue symptoms associated with Gulf War Illness.

What is the current status of trial NCT01700725?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2012-10. Estimated completion is 2017-05.

What interventions are being tested in trial NCT01700725?

The interventions under investigation include: Nasal Irrigation - Saline (OTHER), Nasal Irrigation - Xylitol (DRUG).

Who is sponsoring clinical trial NCT01700725?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01700725's enrollment target sits among peer trials

40 1362nd of 2000 higher than 542 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01700725, the US trial registry maintained by the National Library of Medicine. NCT01700725 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.